APO Research
Talk to an analyst

APO RESEARCH · REPORT

Recombinant Therapeutic Protein

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Recombinant Therapeutic Protein Industry Growth and Trends Forecast to 2032

26 December 2025101 pages

Choose your research edition.

Industry ResearchRecombinant Therapeutic Protein Industry Research Report 2026128 pages · $2,950 USDIndustry Growth & TrendsGlobal Recombinant Therapeutic Protein Industry Growth and Trends Forecast to 2032101 pages · $3,450 USDMarket StructureGlobal Recombinant Therapeutic Protein Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Recombinant Therapeutic Protein Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Recombinant Therapeutic Protein Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

The global Recombinant Therapeutic Protein market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Recombinant Therapeutic Protein is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Recombinant Therapeutic Protein is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Recombinant Therapeutic Protein is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Recombinant Therapeutic Protein include Boehringer Ingelheim, Bristol-Myers Squibb, Celldex Therapeutics, Eli Liily, GlaxoSmithKline, Regeneron Pharmaceuticals, Roche, Merck and Novartis, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Recombinant Therapeutic Protein market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Recombinant Therapeutic Protein market size, estimates, and forecasts are presented in terms of sales volume (Tons) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Recombinant Therapeutic Protein market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Recombinant Therapeutic Protein.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Recombinant Therapeutic Protein market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Recombinant Therapeutic Protein Market by Company

Boehringer Ingelheim

Bristol-Myers Squibb

Celldex Therapeutics

Eli Liily

GlaxoSmithKline

Regeneron Pharmaceuticals

Roche

Merck

Novartis

Takeda

Recombinant Therapeutic Protein Segment by Type

Recombinant Human Collage

Recombinant Human Serum Albumin

Recombinant Therapeutic Protein Segment by Application

Medicine

Scientific Research

Others

Recombinant Therapeutic Protein Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Recombinant Therapeutic Protein market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Recombinant Therapeutic Protein and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Recombinant Therapeutic Protein.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Recombinant Therapeutic Protein manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Recombinant Therapeutic Protein in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Recombinant Human Collage Table 2. Major Company of Recombinant Human Serum Albumin Table 3. Global Recombinant Therapeutic Protein Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Recombinant Therapeutic Protein Sales by Type (2021-2026) & (Tons) Table 5. Global Recombinant Therapeutic Protein Sales Market Share in Volume by Type (2021-2026) Table 6. Global Recombinant Therapeutic Protein Sales by Type (2021-2026) & (US$ Million) Table 7. Global Recombinant Therapeutic Protein Sales Market Share in Value by Type (2021-2026) Table 8. Global Recombinant Therapeutic Protein Price by Type (2021-2026) & (US$/Ton) Table 9. Global Recombinant Therapeutic Protein Sales by Type (2027-2032) & (Tons) Table 10. Global Recombinant Therapeutic Protein Sales Market Share in Volume by Type (2027-2032) Table 11. Global Recombinant Therapeutic Protein Sales by Type (2027-2032) & (US$ Million) Table 12. Global Recombinant Therapeutic Protein Sales Market Share in Value by Type (2027-2032) Table 13. Global Recombinant Therapeutic Protein Price by Type (2027-2032) & (US$/Ton) Table 14. North America Recombinant Therapeutic Protein Sales by Type (2021-2026) & (Tons) Table 15. North America Recombinant Therapeutic Protein Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Recombinant Therapeutic Protein Sales by Type (2021-2026) & (Tons) Table 17. Europe Recombinant Therapeutic Protein Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Recombinant Therapeutic Protein Sales by Type (2021-2026) & (Tons) Table 19. Asia-Pacific Recombinant Therapeutic Protein Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Recombinant Therapeutic Protein Sales by Type (2021-2026) & (Tons) Table 21. Latin America Recombinant Therapeutic Protein Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Recombinant Therapeutic Protein Sales by Type (2021-2026) & (Tons) Table 23. Middle East and Africa Recombinant Therapeutic Protein Sales by Type (2021-2026) & (US$ Million) Table 24. Recombinant Therapeutic Protein Industry Trends Table 25. Recombinant Therapeutic Protein Industry Drivers Table 26. Recombinant Therapeutic Protein Industry Opportunities and Challenges Table 27. Recombinant Therapeutic Protein Industry Restraints Table 28. Global Recombinant Therapeutic Protein Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Recombinant Therapeutic Protein Revenue Market Share by Company (2021-2026) Table 30. Global Recombinant Therapeutic Protein Sales by Company (2021-2026) & (Tons) Table 31. Global Recombinant Therapeutic Protein Sales Share by Company (2021-2026) Table 32. Global Recombinant Therapeutic Protein Market Price by Company (2021-2026) & (US$/Ton) Table 33. Global Recombinant Therapeutic Protein Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Recombinant Therapeutic Protein Major Company Production Sites and Headquarters Table 35. Global Recombinant Therapeutic Protein Company, Product Type & Application Table 36. Global Recombinant Therapeutic Protein Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Recombinant Therapeutic Protein by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Recombinant Therapeutic Protein Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Recombinant Therapeutic Protein Sales by Region (2021-2026) & (Tons) Table 41. Global Recombinant Therapeutic Protein Sales Market Share in Volume by Region (2021-2026) Table 42. Global Recombinant Therapeutic Protein Sales by Region (2021-2026) & (US$ Million) Table 43. Global Recombinant Therapeutic Protein Sales Market Share in Value by Region (2021-2026) Table 44. Global Recombinant Therapeutic Protein Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 45. Global Recombinant Therapeutic Protein Sales by Region (2027-2032) & (Tons) Table 46. Global Recombinant Therapeutic Protein Sales Market Share in Volume by Region (2027-2032) Table 47. Global Recombinant Therapeutic Protein Sales by Region (2027-2032) & (US$ Million) Table 48. Global Recombinant Therapeutic Protein Sales Market Share in Value by Region (2027-2032) Table 49. Global Recombinant Therapeutic Protein Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2027-2032) Table 50. Global Recombinant Therapeutic Protein Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Recombinant Therapeutic Protein Sales by Application (2021-2026) & (Tons) Table 52. Global Recombinant Therapeutic Protein Sales Market Share in Volume by Application (2021-2026) Table 53. Global Recombinant Therapeutic Protein Sales by Application (2021-2026) & (US$ Million) Table 54. Global Recombinant Therapeutic Protein Sales Market Share in Value by Application (2021-2026) Table 55. Global Recombinant Therapeutic Protein Price by Application (2021-2026) & (US$/Ton) Table 56. Global Recombinant Therapeutic Protein Sales by Application (2027-2032) & (Tons) Table 57. Global Recombinant Therapeutic Protein Sales Market Share in Volume by Application (2027-2032) Table 58. Global Recombinant Therapeutic Protein Sales by Application (2027-2032) & (US$ Million) Table 59. Global Recombinant Therapeutic Protein Sales Market Share in Value by Application (2027-2032) Table 60. Global Recombinant Therapeutic Protein Price by Application (2027-2032) & (US$/Ton) Table 61. North America Recombinant Therapeutic Protein Sales by Application (2021-2026) & (Tons) Table 62. North America Recombinant Therapeutic Protein Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Recombinant Therapeutic Protein Sales by Application (2021-2026) & (Tons) Table 64. Europe Recombinant Therapeutic Protein Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Recombinant Therapeutic Protein Sales by Application (2021-2026) & (Tons) Table 66. Asia-Pacific Recombinant Therapeutic Protein Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Recombinant Therapeutic Protein Sales by Application (2021-2026) & (Tons) Table 68. Latin America Recombinant Therapeutic Protein Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Recombinant Therapeutic Protein Sales by Application (2021-2026) & (Tons) Table 70. Middle East and Africa Recombinant Therapeutic Protein Sales by Application (2021-2026) & (US$ Million) Table 71. Boehringer Ingelheim Company Information Table 72. Boehringer Ingelheim Business Overview Table 73. Boehringer Ingelheim Recombinant Therapeutic Protein Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 74. Boehringer Ingelheim Recombinant Therapeutic Protein Product Portfolio Table 75. Boehringer Ingelheim Recent Development Table 76. Bristol-Myers Squibb Company Information Table 77. Bristol-Myers Squibb Business Overview Table 78. Bristol-Myers Squibb Recombinant Therapeutic Protein Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 79. Bristol-Myers Squibb Recombinant Therapeutic Protein Product Portfolio Table 80. Bristol-Myers Squibb Recent Development Table 81. Celldex Therapeutics Company Information Table 82. Celldex Therapeutics Business Overview Table 83. Celldex Therapeutics Recombinant Therapeutic Protein Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 84. Celldex Therapeutics Recombinant Therapeutic Protein Product Portfolio Table 85. Celldex Therapeutics Recent Development Table 86. Eli Liily Company Information Table 87. Eli Liily Business Overview Table 88. Eli Liily Recombinant Therapeutic Protein Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 89. Eli Liily Recombinant Therapeutic Protein Product Portfolio Table 90. Eli Liily Recent Development Table 91. GlaxoSmithKline Company Information Table 92. GlaxoSmithKline Business Overview Table 93. GlaxoSmithKline Recombinant Therapeutic Protein Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 94. GlaxoSmithKline Recombinant Therapeutic Protein Product Portfolio Table 95. GlaxoSmithKline Recent Development Table 96. Regeneron Pharmaceuticals Company Information Table 97. Regeneron Pharmaceuticals Business Overview Table 98. Regeneron Pharmaceuticals Recombinant Therapeutic Protein Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 99. Regeneron Pharmaceuticals Recombinant Therapeutic Protein Product Portfolio Table 100. Regeneron Pharmaceuticals Recent Development Table 101. Roche Company Information Table 102. Roche Business Overview Table 103. Roche Recombinant Therapeutic Protein Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 104. Roche Recombinant Therapeutic Protein Product Portfolio Table 105. Roche Recent Development Table 106. Merck Company Information Table 107. Merck Business Overview Table 108. Merck Recombinant Therapeutic Protein Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 109. Merck Recombinant Therapeutic Protein Product Portfolio Table 110. Merck Recent Development Table 111. Novartis Company Information Table 112. Novartis Business Overview Table 113. Novartis Recombinant Therapeutic Protein Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 114. Novartis Recombinant Therapeutic Protein Product Portfolio Table 115. Novartis Recent Development Table 116. Takeda Company Information Table 117. Takeda Business Overview Table 118. Takeda Recombinant Therapeutic Protein Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 119. Takeda Recombinant Therapeutic Protein Product Portfolio Table 120. Takeda Recent Development Table 121. North America Recombinant Therapeutic Protein Market Size Growth Rate (CAGR) by Country (Tons): 2021 VS 2025 VS 2032 Table 122. North America Recombinant Therapeutic Protein Sales by Country (2021-2026) & (Tons) Table 123. North America Recombinant Therapeutic Protein Sales Market Share by Country (2021-2026) Table 124. North America Recombinant Therapeutic Protein Sales Forecast by Country (2027-2032) & (Tons) Table 125. North America Recombinant Therapeutic Protein Sales Market Share Forecast by Country (2027-2032) Table 126. North America Recombinant Therapeutic Protein Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 127. North America Recombinant Therapeutic Protein Market Size by Country (2021-2026) & (US$ Million) Table 128. North America Recombinant Therapeutic Protein Market Share by Country (2021-2026) Table 129. North America Recombinant Therapeutic Protein Market Size Forecast by Country (2027-2032) & (US$ Million) Table 130. North America Recombinant Therapeutic Protein Market Share Forecast by Country (2027-2032) Table 131. Europe Recombinant Therapeutic Protein Market Size Growth Rate (CAGR) by Country (Tons): 2021 VS 2025 VS 2032 Table 132. Europe Recombinant Therapeutic Protein Sales by Country (2021-2026) & (Tons) Table 133. Europe Recombinant Therapeutic Protein Sales Market Share by Country (2021-2026) Table 134. Europe Recombinant Therapeutic Protein Sales Forecast by Country (2027-2032) & (Tons) Table 135. Europe Recombinant Therapeutic Protein Sales Market Share Forecast by Country (2027-2032) Table 136. Europe Recombinant Therapeutic Protein Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 137. Europe Recombinant Therapeutic Protein Market Size by Country (2021-2026) & (US$ Million) Table 138. Europe Recombinant Therapeutic Protein Market Share by Country (2021-2026) Table 139. Europe Recombinant Therapeutic Protein Market Size Forecast by Country (2027-2032) & (US$ Million) Table 140. Europe Recombinant Therapeutic Protein Market Share Forecast by Country (2027-2032) Table 141. Asia-Pacific Recombinant Therapeutic Protein Market Size Growth Rate (CAGR) by Country (Tons): 2021 VS 2025 VS 2032 Table 142. Asia-Pacific Recombinant Therapeutic Protein Sales by Country (2021-2026) & (Tons) Table 143. Asia-Pacific Recombinant Therapeutic Protein Sales Market Share by Country (2021-2026) Table 144. Asia-Pacific Recombinant Therapeutic Protein Sales Forecast by Country (2027-2032) & (Tons) Table 145. Asia-Pacific Recombinant Therapeutic Protein Sales Market Share Forecast by Country (2027-2032) Table 146. Asia-Pacific Recombinant Therapeutic Protein Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 147. Asia-Pacific Recombinant Therapeutic Protein Market Size by Country (2021-2026) & (US$ Million) Table 148. Asia-Pacific Recombinant Therapeutic Protein Market Share by Country (2021-2026) Table 149. Asia-Pacific Recombinant Therapeutic Protein Market Size Forecast by Country (2027-2032) & (US$ Million) Table 150. Asia-Pacific Recombinant Therapeutic Protein Market Share Forecast by Country (2027-2032) Table 151. Latin America Recombinant Therapeutic Protein Market Size Growth Rate (CAGR) by Country (Tons): 2021 VS 2025 VS 2032 Table 152. Latin America Recombinant Therapeutic Protein Sales by Country (2021-2026) & (Tons) Table 153. Latin America Recombinant Therapeutic Protein Sales Market Share by Country (2021-2026) Table 154. Latin America Recombinant Therapeutic Protein Sales Forecast by Country (2027-2032) & (Tons) Table 155. Latin America Recombinant Therapeutic Protein Sales Market Share Forecast by Country (2027-2032) Table 156. Latin America Recombinant Therapeutic Protein Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 157. Latin America Recombinant Therapeutic Protein Market Size by Country (2021-2026) & (US$ Million) Table 158. Latin America Recombinant Therapeutic Protein Market Share by Country (2021-2026) Table 159. Latin America Recombinant Therapeutic Protein Market Size Forecast by Country (2027-2032) & (US$ Million) Table 160. Latin America Recombinant Therapeutic Protein Market Share Forecast by Country (2027-2032) Table 161. Middle East and Africa Recombinant Therapeutic Protein Market Size Growth Rate (CAGR) by Country (Tons): 2021 VS 2025 VS 2032 Table 162. Middle East and Africa Recombinant Therapeutic Protein Sales by Country (2021-2026) & (Tons) Table 163. Middle East and Africa Recombinant Therapeutic Protein Sales Market Share by Country (2021-2026) Table 164. Middle East and Africa Recombinant Therapeutic Protein Sales Forecast by Country (2027-2032) & (Tons) Table 165. Middle East and Africa Recombinant Therapeutic Protein Sales Market Share Forecast by Country (2027-2032) Table 166. Middle East and Africa Recombinant Therapeutic Protein Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 167. Middle East and Africa Recombinant Therapeutic Protein Market Size by Country (2021-2026) & (US$ Million) Table 168. Middle East and Africa Recombinant Therapeutic Protein Market Share by Country (2021-2026) Table 169. Middle East and Africa Recombinant Therapeutic Protein Market Size Forecast by Country (2027-2032) & (US$ Million) Table 170. Middle East and Africa Recombinant Therapeutic Protein Market Share Forecast by Country (2027-2032) Table 171. Key Raw Materials Table 172. Raw Materials Key Suppliers Table 173. Recombinant Therapeutic Protein Distributors List Table 174. Recombinant Therapeutic Protein Customers List Table 175. Research Programs/Design for This Report Table 176. Authors List of This Report Table 177. Secondary Sources Table 178. Primary Sources List of Figures Figure 1. Recombinant Therapeutic Protein Image Figure 2. Global Recombinant Therapeutic Protein Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Recombinant Therapeutic Protein Market Size (2021-2032) & (US$ Million) Figure 4. Global Recombinant Therapeutic Protein Sales (2021-2032) & (Tons) Figure 5. Recombinant Human Collage Image Figure 6. Global Recombinant Human Collage Sales YoY Growth (2021-2032) & (Tons) Figure 7. Recombinant Human Serum Albumin Image Figure 8. Global Recombinant Human Serum Albumin Sales YoY Growth (2021-2032) & (Tons) Figure 9. Global Recombinant Therapeutic Protein Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Recombinant Therapeutic Protein Market Share by Type 2025 VS 2032 Figure 11. North America Recombinant Therapeutic Protein Sales Market Share in Volume by Type in 2025 Figure 12. North America Recombinant Therapeutic Protein Sales Market Share in Value by Type in 2025 Figure 13. Europe Recombinant Therapeutic Protein Sales Market Share in Volume by Type in 2025 Figure 14. Europe Recombinant Therapeutic Protein Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Recombinant Therapeutic Protein Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Recombinant Therapeutic Protein Sales Market Share in Value by Type in 2025 Figure 17. Latin America Recombinant Therapeutic Protein Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Recombinant Therapeutic Protein Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Recombinant Therapeutic Protein Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Recombinant Therapeutic Protein Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Recombinant Therapeutic Protein Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Medicine Image Figure 24. Global Medicine Sales YoY Growth (2021-2032) & (Tons) Figure 25. Scientific Research Image Figure 26. Global Scientific Research Sales YoY Growth (2021-2032) & (Tons) Figure 27. Others Image Figure 28. Global Others Sales YoY Growth (2021-2032) & (Tons) Figure 29. Global Recombinant Therapeutic Protein Market Size Overview by Application (2021-2032) & (US$ Million) Figure 30. Global Recombinant Therapeutic Protein Market Share by Application 2025 VS 2032 Figure 31. North America Recombinant Therapeutic Protein Sales Market Share in Volume by Application in 2025 Figure 32. North America Recombinant Therapeutic Protein Sales Market Share in Value by Application in 2025 Figure 33. Europe Recombinant Therapeutic Protein Sales Market Share in Volume by Application in 2025 Figure 34. Europe Recombinant Therapeutic Protein Sales Market Share in Value by Application in 2025 Figure 35. Asia-Pacific Recombinant Therapeutic Protein Sales Market Share in Volume by Application in 2025 Figure 36. Asia-Pacific Recombinant Therapeutic Protein Sales Market Share in Value by Application in 2025 Figure 37. Latin America Recombinant Therapeutic Protein Sales Market Share in Volume by Application in 2025 Figure 38. Latin America Recombinant Therapeutic Protein Sales Market Share in Value by Application in 2025 Figure 39. Middle East and Africa Recombinant Therapeutic Protein Sales Market Share in Volume by Application in 2025 Figure 40. Middle East and Africa Recombinant Therapeutic Protein Sales Market Share in Value by Application in 2025 Figure 41. North America Recombinant Therapeutic Protein Sales by Country: 2021 VS 2025 VS 2032 (Tons) Figure 42. North America Recombinant Therapeutic Protein Sales Share by Country: 2021 VS 2025 VS 2032 Figure 43. North America Recombinant Therapeutic Protein Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 44. North America Recombinant Therapeutic Protein Market Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Recombinant Therapeutic Protein Sales by Country: 2021 VS 2025 VS 2032 (Tons) Figure 46. Europe Recombinant Therapeutic Protein Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Recombinant Therapeutic Protein Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Europe Recombinant Therapeutic Protein Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Recombinant Therapeutic Protein Sales by Country: 2021 VS 2025 VS 2032 (Tons) Figure 50. Asia-Pacific Recombinant Therapeutic Protein Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Recombinant Therapeutic Protein Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Asia-Pacific Recombinant Therapeutic Protein Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Recombinant Therapeutic Protein Sales by Country: 2021 VS 2025 VS 2032 (Tons) Figure 54. Latin America Recombinant Therapeutic Protein Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Recombinant Therapeutic Protein Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Latin America Recombinant Therapeutic Protein Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Recombinant Therapeutic Protein Sales by Country: 2021 VS 2025 VS 2032 (Tons) Figure 58. Middle East and Africa Recombinant Therapeutic Protein Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Recombinant Therapeutic Protein Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Middle East and Africa Recombinant Therapeutic Protein Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Recombinant Therapeutic Protein Value Chain Figure 62. Key Raw Materials Price Figure 63. Manufacturing Cost Structure Figure 64. Recombinant Therapeutic Protein Production Mode & Process Figure 65. Direct Comparison with Distribution Share Figure 66. Distributors Profiles Figure 67. Years Considered Figure 68. Research Process Figure 69. Key Executives Interviewed

Scope & coverage.

Types
  • Recombinant Human Collage
  • Recombinant Human Serum Albumin
Applications
  • Medicine
  • Scientific Research
  • Others
Companies covered
  • Boehringer Ingelheim
  • Bristol-Myers Squibb
  • Celldex Therapeutics
  • Eli Liily
  • GlaxoSmithKline
  • Regeneron Pharmaceuticals
  • Roche
  • Merck
  • Novartis
  • Takeda

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Recombinant Therapeutic Protein Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Recombinant Therapeutic Protein Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Recombinant Therapeutic Protein Market by Type
  6. 1.3.1 Recombinant Human Collage
  7. 1.3.2 Recombinant Human Serum Albumin
  8. 1.4 Global Recombinant Therapeutic Protein Market Size by Type
  9. 1.4.1 Global Recombinant Therapeutic Protein Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Recombinant Therapeutic Protein Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Recombinant Therapeutic Protein Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Recombinant Therapeutic Protein Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Recombinant Therapeutic Protein Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Recombinant Therapeutic Protein Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Recombinant Therapeutic Protein Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Recombinant Therapeutic Protein Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Recombinant Therapeutic Protein Industry Trends
  2. 2.2 Recombinant Therapeutic Protein Industry Drivers
  3. 2.3 Recombinant Therapeutic Protein Industry Opportunities and Challenges
  4. 2.4 Recombinant Therapeutic Protein Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Recombinant Therapeutic Protein Revenue (2021-2026)
  2. 3.2 Global Top Players by Recombinant Therapeutic Protein Sales (2021-2026)
  3. 3.3 Global Top Players by Recombinant Therapeutic Protein Price (2021-2026)
  4. 3.4 Global Recombinant Therapeutic Protein Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Recombinant Therapeutic Protein Major Company Production Sites & Headquarters
  6. 3.6 Global Recombinant Therapeutic Protein Company, Product Type & Application
  7. 3.7 Global Recombinant Therapeutic Protein Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Recombinant Therapeutic Protein Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Recombinant Therapeutic Protein Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Recombinant Therapeutic Protein Tier 1, Tier 2, and Tier 3
4 Recombinant Therapeutic Protein Regional Status and Outlook
  1. 4.1 Global Recombinant Therapeutic Protein Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Recombinant Therapeutic Protein Historic Market Size by Region
  3. 4.2.1 Global Recombinant Therapeutic Protein Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Recombinant Therapeutic Protein Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Recombinant Therapeutic Protein Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Recombinant Therapeutic Protein Forecasted Market Size by Region
  7. 4.3.1 Global Recombinant Therapeutic Protein Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Recombinant Therapeutic Protein Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Recombinant Therapeutic Protein Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Recombinant Therapeutic Protein by Application
  1. 5.1 Recombinant Therapeutic Protein Market by Application
  2. 5.1.1 Medicine
  3. 5.1.2 Scientific Research
  4. 5.1.3 Others
  5. 5.2 Global Recombinant Therapeutic Protein Market Size by Application
  6. 5.2.1 Global Recombinant Therapeutic Protein Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Recombinant Therapeutic Protein Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Recombinant Therapeutic Protein Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Recombinant Therapeutic Protein Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Recombinant Therapeutic Protein Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Recombinant Therapeutic Protein Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Recombinant Therapeutic Protein Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Recombinant Therapeutic Protein Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Boehringer Ingelheim
  2. 6.1.1 Boehringer Ingelheim Company Information
  3. 6.1.2 Boehringer Ingelheim Business Overview
  4. 6.1.3 Boehringer Ingelheim Recombinant Therapeutic Protein Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Boehringer Ingelheim Recombinant Therapeutic Protein Product Portfolio
  6. 6.1.5 Boehringer Ingelheim Recent Developments
  7. 6.2 Bristol-Myers Squibb
  8. 6.2.1 Bristol-Myers Squibb Company Information
  9. 6.2.2 Bristol-Myers Squibb Business Overview
  10. 6.2.3 Bristol-Myers Squibb Recombinant Therapeutic Protein Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Bristol-Myers Squibb Recombinant Therapeutic Protein Product Portfolio
  12. 6.2.5 Bristol-Myers Squibb Recent Developments
  13. 6.3 Celldex Therapeutics
  14. 6.3.1 Celldex Therapeutics Company Information
  15. 6.3.2 Celldex Therapeutics Business Overview
  16. 6.3.3 Celldex Therapeutics Recombinant Therapeutic Protein Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Celldex Therapeutics Recombinant Therapeutic Protein Product Portfolio
  18. 6.3.5 Celldex Therapeutics Recent Developments
  19. 6.4 Eli Liily
  20. 6.4.1 Eli Liily Company Information
  21. 6.4.2 Eli Liily Business Overview
  22. 6.4.3 Eli Liily Recombinant Therapeutic Protein Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Eli Liily Recombinant Therapeutic Protein Product Portfolio
  24. 6.4.5 Eli Liily Recent Developments
  25. 6.5 GlaxoSmithKline
  26. 6.5.1 GlaxoSmithKline Company Information
  27. 6.5.2 GlaxoSmithKline Business Overview
  28. 6.5.3 GlaxoSmithKline Recombinant Therapeutic Protein Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 GlaxoSmithKline Recombinant Therapeutic Protein Product Portfolio
  30. 6.5.5 GlaxoSmithKline Recent Developments
  31. 6.6 Regeneron Pharmaceuticals
  32. 6.6.1 Regeneron Pharmaceuticals Company Information
  33. 6.6.2 Regeneron Pharmaceuticals Business Overview
  34. 6.6.3 Regeneron Pharmaceuticals Recombinant Therapeutic Protein Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Regeneron Pharmaceuticals Recombinant Therapeutic Protein Product Portfolio
  36. 6.6.5 Regeneron Pharmaceuticals Recent Developments
  37. 6.7 Roche
  38. 6.7.1 Roche Company Information
  39. 6.7.2 Roche Business Overview
  40. 6.7.3 Roche Recombinant Therapeutic Protein Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Roche Recombinant Therapeutic Protein Product Portfolio
  42. 6.7.5 Roche Recent Developments
  43. 6.8 Merck
  44. 6.8.1 Merck Company Information
  45. 6.8.2 Merck Business Overview
  46. 6.8.3 Merck Recombinant Therapeutic Protein Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Merck Recombinant Therapeutic Protein Product Portfolio
  48. 6.8.5 Merck Recent Developments
  49. 6.9 Novartis
  50. 6.9.1 Novartis Company Information
  51. 6.9.2 Novartis Business Overview
  52. 6.9.3 Novartis Recombinant Therapeutic Protein Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Novartis Recombinant Therapeutic Protein Product Portfolio
  54. 6.9.5 Novartis Recent Developments
  55. 6.10 Takeda
  56. 6.10.1 Takeda Company Information
  57. 6.10.2 Takeda Business Overview
  58. 6.10.3 Takeda Recombinant Therapeutic Protein Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Takeda Recombinant Therapeutic Protein Product Portfolio
  60. 6.10.5 Takeda Recent Developments
7 North America by Country
  1. 7.1 North America Recombinant Therapeutic Protein Sales by Country
  2. 7.1.1 North America Recombinant Therapeutic Protein Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Recombinant Therapeutic Protein Sales by Country (2021-2026)
  4. 7.1.3 North America Recombinant Therapeutic Protein Sales Forecast by Country (2027-2032)
  5. 7.2 North America Recombinant Therapeutic Protein Market Size by Country
  6. 7.2.1 North America Recombinant Therapeutic Protein Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Recombinant Therapeutic Protein Market Size by Country (2021-2026)
  8. 7.2.3 North America Recombinant Therapeutic Protein Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Recombinant Therapeutic Protein Sales by Country
  2. 8.1.1 Europe Recombinant Therapeutic Protein Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Recombinant Therapeutic Protein Sales by Country (2021-2026)
  4. 8.1.3 Europe Recombinant Therapeutic Protein Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Recombinant Therapeutic Protein Market Size by Country
  6. 8.2.1 Europe Recombinant Therapeutic Protein Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Recombinant Therapeutic Protein Market Size by Country (2021-2026)
  8. 8.2.3 Europe Recombinant Therapeutic Protein Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Recombinant Therapeutic Protein Sales by Country
  2. 9.1.1 Asia-Pacific Recombinant Therapeutic Protein Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Recombinant Therapeutic Protein Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Recombinant Therapeutic Protein Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Recombinant Therapeutic Protein Market Size by Country
  6. 9.2.1 Asia-Pacific Recombinant Therapeutic Protein Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Recombinant Therapeutic Protein Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Recombinant Therapeutic Protein Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Recombinant Therapeutic Protein Sales by Country
  2. 10.1.1 South America Recombinant Therapeutic Protein Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Recombinant Therapeutic Protein Sales by Country (2021-2026)
  4. 10.1.3 South America Recombinant Therapeutic Protein Sales Forecast by Country (2027-2032)
  5. 10.2 South America Recombinant Therapeutic Protein Market Size by Country
  6. 10.2.1 South America Recombinant Therapeutic Protein Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Recombinant Therapeutic Protein Market Size by Country (2021-2026)
  8. 10.2.3 South America Recombinant Therapeutic Protein Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Recombinant Therapeutic Protein Sales by Country
  2. 11.1.1 Middle East and Africa Recombinant Therapeutic Protein Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Recombinant Therapeutic Protein Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Recombinant Therapeutic Protein Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Recombinant Therapeutic Protein Market Size by Country
  6. 11.2.1 Middle East and Africa Recombinant Therapeutic Protein Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Recombinant Therapeutic Protein Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Recombinant Therapeutic Protein Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Recombinant Therapeutic Protein Value Chain Analysis
  2. 12.1.1 Recombinant Therapeutic Protein Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Recombinant Therapeutic Protein Production Mode & Process
  7. 12.2 Recombinant Therapeutic Protein Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Recombinant Therapeutic Protein Distributors
  10. 12.2.3 Recombinant Therapeutic Protein Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst